We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Scancell Holdings Plc | LSE:SCLP | London | Ordinary Share | GB00B63D3314 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.475 | 5.05% | 9.875 | 9.50 | 10.25 | 9.875 | 9.09 | 9.40 | 699,855 | 09:00:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.27M | -11.94M | -0.0129 | -7.65 | 91.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
28/11/2017 12:04 | 3 parrot posts ... pretty well backed up what i posted LOL | inanaco | |
28/11/2017 11:35 | Come on Nappy.... back your post up.... | tosh123 | |
28/11/2017 11:28 | Nappy... " nobody agrees with you on your take of Scancell " hahahaha... so you're now telling me that you speak for everyone hahaha.... How arrogant and self professing can any person be hahahaha... Brilliant ! I would suggest that you are, just for a change, 100% WRONG... Prove that nobody agrees with me ... Go on you idiot, back your post up with proof... i cant wait for this attempt to wriggle out of yet another LIE. | tosh123 | |
28/11/2017 11:10 | Tosh, your Parrot posting .. | inanaco | |
28/11/2017 11:09 | Tosh nobody agrees with you on your take of Scancell . apart from Loz and if anybody missed Lozs take on the science """"including the over-rated 'science' as being the sole aspect to financial success here""" LOL maybe you can explain overrated Loz ... and how you came to that definition and also what other aspect is in play to financial success ? | inanaco | |
27/11/2017 23:34 | Goy ... thought your stereo was a pair of headphones ? | inanaco | |
27/11/2017 23:09 | Boom that backs up exactly what i was discussing with you ......on the LSE Results are consistent with the hypothesis that Pads are activated within stressed tumor cells leading to generation and presentation of citrullinated epitopes that are recognised by T cells and killed more you stress, the more expression ....hence the slew to a TH1 cd4* which is pro inflammatory pity Loz didn't have the brain to follow the light bulb .. | inanaco | |
27/11/2017 21:44 | Nappy - YOUR runaway EGO may have led YOU to believe that YOU are some sort of 'superior in all matters SCLP to ALL others'...including the over-rated 'science' as being the sole aspect to financial success here. BUT, *WE* ALL know that is merely to try to 'establish YOURSELF' as someone to 'follow'. Those who fell for this have ONLY 'followed YOU into LOSSES Rather than the "Bright Light" YOUR EGO elevates YOU to, there are many many observers of these forums, who would not rely on YOU, think YOU capable, or TRUST YOU to ... 'Clear a blocked drain' | the real lozan | |
27/11/2017 21:31 | The following link is courtesy of Scrumpy. Looks like Scancell have added another poster to their website:- "Protein Arginine Deiminase enzymes which citrullinate epitopes for MHC II presentation are independent predictors of survival in colorectal cancer" The research may have been published last year but think the poster has recently been added to Scancell's website (apologies if I've just missed it). PADs are enzymes which are responsible for citrullination. The conclusion on the poster is worth reading as it supports the reasoning behind Moditope. "Patients with tumor that expresses either PadI2 or Cytoplasmic PadI4 have a better prognosis in colorectal cancer. Results are consistent with the hypothesis that Pads are activated within stressed tumor cells leading to generation and presentation of citrullinated epitopes that are recognised by T cells and killed. Tumor growth is controlled by T cells and the patient has a better prognosis." | bermudashorts | |
27/11/2017 21:03 | goy - yes good day there today. | bermudashorts | |
27/11/2017 20:53 | Inan - you're right, I am conflicted because I don't understand a word of the above. Going to leave it there. | bermudashorts | |
27/11/2017 20:45 | I see the lights on outside, Bugs are flying in . i just wonder why they get attracted to the bright lights, maybe the dulls ones don't offer the same appeal ..anyway never seen a bug break a light. | inanaco | |
27/11/2017 20:33 | by classing my post as patronising ... when really the evidence of you supporting poor posts is very clear, example the 7 trials 7 deals posts ... what a fuss you made of that, indeed compared to my replies today it was making Mountains out of molehills.. i will give you another example the other day you moaned about portfolio investing. Why my policy of investing in scancell should be of concern, i explained why ie understanding of the science and the sheer number of potentials to the pipeline ....your posts actually support exactly what i have been saying. Thus your conflicted but is that because its gets you the chance to a have a dig or ? the other day you posted this to ONW SCLPONW12 Oct '17 Usually I either broadly agree or just mildly disagree with your posts but in this case I have completely opposite opinion lol! Most people would accept that the wider and the deeper the pipeline, the more attractive the company. Indeed, bios. spend vast amounts of time and money trying to achieve just that. Scancell are fortunate and have LD's brilliant innovation but many have to buy in the tech. The reason they do that is to avoid being classed as a one trick pony. If other bios./pharma want to acquire only one platform of just one product from the platform, it's no problem, the deal will simply be structured accordingly. I happens day in and day out. You think that having 2 platforms is a potential issue where as I think it -------------------- Now for sure you cannot dispute that i have more than just investor knowledge in my understanding of the science. Your also aware of my history and i also am aware of yours, indeed i have pointed out that Corporate stuff is best left to you, so you cannot point the finger and say I am patronising, however you could not trust some posters on the lse to get the science correct when most admit they don't really need to understand it. Tosh in the past has posted as such. Lets be honest here eh !! Hardly any party posts conclusions on the LSE and instead ask you or me to translate the science into something they can relate to. so looking from the outside in .. one party has to have a certain authority to do that. so you cannot then say they are being patronising when most of the time that's the role that's expected of them ie ... it makes no sense unless you have a chip on your shoulder. | inanaco | |
27/11/2017 20:14 | Onan, is there a sentient adult in your house that can read your typed exercises in self-absorption, paranoia and pomposity before you post? You are beyond parody, it is receding in the rear view mirror. I picture you in the garage with a First Chemistry Set, bedecked in a white coat and safety spectacles, screaming scientific inanity like some lobotomised Joe 90 figure. | goyathlay | |
27/11/2017 20:11 | Try and pass the buck? What do you mean? | bermudashorts | |
27/11/2017 20:06 | Smiler so is "go and find the negative" ..... lol | inanaco | |
27/11/2017 20:05 | Just posting as i see it Boom ... you can try and pass the buck ... however the history of that is in print. ATB | inanaco | |
27/11/2017 19:57 | BoB, it's the trait of being narcissistic, I wouldn't bother replying to him. He needs help with the condition, best to ignore him, won't be long before he implodes in his self importance. | wanderer1210_0 | |
27/11/2017 19:55 | Twitter Social media .. is not a good place for Rolls Royce to advertise jet engines to some arab airline ... it maybe a good place to create propaganda for "momentum brain washing" for those that do want to live in a Venezuela Style Economy point being ... share price to twitter ratings is zero ... as of this moment in time. sp it's not a powerful platform for Scancell .... and never will be IMHO | inanaco |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions